Tall Allen said...
The Axumin PET is available for men with a biochemical recurrence at Loyola U Medical center.
Check with your insurance - FDA approval doesn't automatically mean it will be covered....
TA makes a good point. This is a valid caution for anyone considering advanced scans. My insurance won't even cover C11-Choline, saying it's not "proven for prostate cancer". I haven't asked yet, but I'm betting they won't approve anything beyond the traditional tech-99 bone scan or common CT. "If those don't find it, it's not worth finding", I suppose would be their argument.
As one contemplating possible biochemical recurrence, these scans are of interest. If warranted, I'll do one, but it's going to be out of pocket. So for likely $3k+, it had better be worth it! I wouldn't do the scan unless it will affect the course of treatment from that point.
In engineering tests, my rule has always been that unless you're going to change your actions based on the result of the test, don't do the test.
Bx: 6/12 pos, G9=5+4 (80%, 60%), 4+5 (2@100%, 80%, 10%), PNI+
cT3a (3TMRI: Bilateral EPE, NVB+, SV-, LN-)
Date PSA fPSA
9/12 4.1 15%
3/13 5.2 12% PCA3=31
IGRT by IMRT, 44 done 8/28/13: 50.4 Gy pelvic nodes, 79.2 Gy prostate
ADT2 3 yrs: Lupron/Casodex, ended 3/16
Post: (age now 59)
PSA <0.1 : 8/13 - 5/16.
PSA 0.2-8/16, 0.5-12/16, TBD-3/17